Irritation of the anterior segment of the eye by ultraviolet radiation: influence of nerve blockade and calcium antagonists.
The aim of this investigation was to determine the influence on anterior segment inflammation elicited by UV radiation, of ocular denervation and pharmacological blockade of sensory nerve fibers with capsaicin, tetrodotoxin and calcium antagonists. Both eyes of pigmented rabbits were exposed for 5 min to UV radiation (254 nm); 24 h later, inflammatory signs were evaluated by biomicroscopy of the corneal epithelium, the stroma and the endothelium and scored from 0 to 4. Conjunctival vasodilation and miosis were also assessed. Two weeks before UV exposure, a group of rabbits received a retrobulbar injection of ethanol or of 1% capsaicin. Intact, capsaicin-treated and alcohol-denervated animals were treated topically, prior to UV exposure, with tetrodotoxin (0.78 mM) and the calcium antagonists diltiazem (1-28 mM) and nifedipine (10 mM). UV radiation produced at 24 h signs of corneal irritation, conjunctival hyperemia, miosis and elevated protein content of the aqueous humor. Retrobulbar injection of 99% alcohol or 1% capsaicin did not diminish significantly the inflammation of tissues directly exposed to UV radiation, although extension of inflammatory signs to unaffected areas was prevented. Pre-treatment of normal and denervated eyes with diltiazem attenuated UV-induced eye irritation signs at concentrations of 10 mM or over. The effect was less pronounced with tetrodotoxin and was not obtained with nifedipine. These findings suggest that the contribution of a neurogenic mechanism to anterior segment inflammation induced by UV exposure is modest. They also show that high concentrations of diltiazem, but not of nifedipine, effectively reduced inflammation of the anterior segment of the eye evoked by UV radiation.(ABSTRACT TRUNCATED AT 250 WORDS)
Gallar
J
J
Departamento de Fisiologia, Universidad de Alicante, Spain.
Garcia de la Rubia
P
P
Gonzalez
G G
GG
Belmonte
C
C
D000818:Animals; D000869:Anterior Eye Segment / Q000294:innervation* / Q000528:radiation effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000627:therapeutic use; D003231:Conjunctivitis / Q000209:etiology / Q000517:prevention & control; D003714:Denervation; D004110:Diltiazem / Q000008:administration & dosage / Q000627:therapeutic use; D007267:Injections; D007634:Keratitis / Q000209:etiology / Q000517:prevention & control; D009543:Nifedipine / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D013779:Tetrodotoxin / Q000008:administration & dosage / Q000627:therapeutic use; D014466:Ultraviolet Rays / Q000009:adverse effects*
D002121:Calcium Channel Blockers; D013779:Tetrodotoxin; D004110:Diltiazem; D009543:Nifedipine